EC
RVNC

EntryPoint Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

EntryPoint Capital’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,906
Closed -$97.9K – 1740
2024
Q1 		$97.9K Buy
19,906
+10,400
+109% +$51.2K 0.09% 433
2023
Q4 		$83.6K Buy
+9,506
New +$83.6K 0.08% 471